机器人手术:最近的进展和结果
Makoto Hibino1, Douglas A Murphy2, Michael E Halkos2
1Department of Thoracic and Cardiovascular Surgery, Heart, Vascular, and Thoracic Institute, Cleveland Clinic Cleveland, Ohio.
Current opinion in cardiology
|September 10, 2024
概括
机器人心肌门手术显示显著增加,与传统方法相比,提供可比的死亡率,但降低了病率. 这种方法对各种疾病和患者群体有效.
科学领域:
- 心脏外科手术 心脏外科手术
- 最少侵入性的技术
- 机器人手术 机器人手术
背景情况:
- 机器人心脏手术是一个不断发展的领域.
- mitra 门手术传统上涉及椎切除或胸腔切除.
- 机器人技术的进步为心脏手术提供了潜在的好处.
研究的目的:
- 审查最近在心脏手术机器人心脏手术中取得的进展,以进行中枢干预.
- 提供当前临床实践和证据的概述.
- 评估机器人中门手术的有效性和安全性.
主要方法:
- 关于机器人 mitra 门手术研究的文献综述.
- 分析STS数据库中关于外科手术方法的数据.
- 对结局,发病率和死亡率的证据综合.
主要成果:
- 机器人中门修复从2015年到2021年增加了30%,而以胸腔切除为基础的修复下降了.
- 机器人修复显示了比较可比的死亡率和较低的发病率比胸切除/胸腔切除.
- 观察到减少了ICU停留时间,减少了再入院,减少了转换为门更换.
- 机器人技术对各种病理和高风险患者具有多样性.
结论:
- 证据支持机器人方法在 mitra 门手术中的采用越来越多.
- 机器人手术提供了可比的疗效,并改善了安全性.
- 这些技术在各种患者形状和复杂病例中表现有前途,这表明 mitra 干预措施的转变.
相关概念视频
Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...


